WallStreetZenWallStreetZen

NASDAQ: BMRN
Biomarin Pharmaceutical Inc Stock Ownership - Who owns Biomarin Pharmaceutical?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Biomarin Pharmaceutical Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
George Eric DavisEVP Chief Legal Officer2026-03-181,273$56.05
$71.35kSell
Brian MuellerEVP Chief Financial Officer2026-03-172,117$56.05
$118.66kSell
Cristin HubbardEVP Chief Commercial Officer2026-03-171,245$56.05
$69.78kSell
Gregory R. FribergEVP Chief RD Officer2026-03-171,629$56.05
$91.31kSell
Alexander HardyChief Executive Officer2026-03-174,252$56.05
$238.32kSell
Charles Greg GuyerEVP Chief Technical Officer2026-03-171,693$56.05
$94.89kSell
George Eric DavisEVP Chief Legal Officer2026-03-167,177$58.51
$419.93kSell
Charles Greg GuyerEVP Chief Technical Officer2026-03-139,109$58.51
$532.97kSell
Alexander HardyChief Executive Officer2026-03-132,941$58.51
$172.08kSell
Brian MuellerEVP Chief Financial Officer2026-03-139,945$58.51
$581.88kSell

1 of 3

BMRN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BMRN insiders and whales buy or sell their stock.

BMRN Shareholders

What type of owners hold Biomarin Pharmaceutical Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc9.95%19,135,108$1.04BInstitution
Vanguard Group Inc9.43%18,127,847$981.44MInstitution
Dodge Cox7.58%14,572,384$788.95MInstitution
Primecap Management Co7.57%14,549,314$787.70MInstitution
Norges Bank3.92%7,531,080$407.73MInstitution
State Street Corp3.91%7,523,218$407.31MInstitution
Aqr Capital Management LLC3.48%6,686,916$362.03MInstitution
Viking Global Investors LP3.14%6,036,936$326.84MInstitution
Geode Capital Management LLC1.91%3,674,089$198.92MInstitution
Dimensional Fund Advisors LP1.73%3,321,754$179.84MInstitution

1 of 3

BMRN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BMRN97.84%1.79%Net SellingNet Selling
EXEL94.72%5.28%Net SellingNet Selling
JAZZ28.78%71.22%Net SellingNet Selling
MDGL26.15%73.85%Net BuyingNet Selling
IONS96.87%3.13%Net SellingNet Selling
View Top Biotech Stocks

Biomarin Pharmaceutical Stock Ownership FAQ

Who owns Biomarin Pharmaceutical?

Biomarin Pharmaceutical (NASDAQ: BMRN) is owned by 97.84% institutional shareholders, 1.79% Biomarin Pharmaceutical insiders, and 0.36% retail investors. Blackrock Inc is the largest individual Biomarin Pharmaceutical shareholder, owning 19.14M shares representing 9.95% of the company. Blackrock Inc's Biomarin Pharmaceutical shares are currently valued at $1.05B.

If you're new to stock investing, here's how to buy Biomarin Pharmaceutical stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.